Pharmaceuticals News and Research

RSS
Syndax to present entinostat data against cancer at AACR meeting

Syndax to present entinostat data against cancer at AACR meeting

1 Apr 2011
Positive outcome from Orexo's OX51 initial pharmacokinetic trial to treat acute intensive pain

Positive outcome from Orexo's OX51 initial pharmacokinetic trial to treat acute intensive pain

1 Apr 2011
Watson, GeneraMedix receive FDA approval for Nulecit to treat iron deficiency anemia

Watson, GeneraMedix receive FDA approval for Nulecit to treat iron deficiency anemia

1 Apr 2011
Positive results from Intercept OCA Phase II trial in patients with PBC

Positive results from Intercept OCA Phase II trial in patients with PBC

1 Apr 2011
Alnylam completes patient enrollment in ALN-VSP Phase I trial against liver cancer

Alnylam completes patient enrollment in ALN-VSP Phase I trial against liver cancer

1 Apr 2011
China BCT fourth quarter revenue increases 82.3% to $66.8 million

China BCT fourth quarter revenue increases 82.3% to $66.8 million

31 Mar 2011
Asuragen launches new miRNA Biofluids service offering

Asuragen launches new miRNA Biofluids service offering

31 Mar 2011
FDA grants Nile Fast Track designation for cenderitide post-acute development program

FDA grants Nile Fast Track designation for cenderitide post-acute development program

31 Mar 2011
Sinovac reports fourth quarter net sales of $9.1 million

Sinovac reports fourth quarter net sales of $9.1 million

31 Mar 2011
Vanda to initiate tasimelteon Phase IIb/III clinical trial in Major Depressive Disorder

Vanda to initiate tasimelteon Phase IIb/III clinical trial in Major Depressive Disorder

31 Mar 2011
Protox reports net loss of $4.5 million for year ended December 31, 2010

Protox reports net loss of $4.5 million for year ended December 31, 2010

31 Mar 2011
RXi Pharmaceuticals to acquire Apthera

RXi Pharmaceuticals to acquire Apthera

31 Mar 2011
Adeona reports $3,164,512 net revenue for 2010

Adeona reports $3,164,512 net revenue for 2010

31 Mar 2011
Vertex announces interim results from VX-222 ongoing Phase 2 study against hepatitis C

Vertex announces interim results from VX-222 ongoing Phase 2 study against hepatitis C

31 Mar 2011
Pacira reports net loss of $7.0 million for quarter ended December 31, 2010

Pacira reports net loss of $7.0 million for quarter ended December 31, 2010

31 Mar 2011
SMFM praises FDA's announcement on Makena drug

SMFM praises FDA's announcement on Makena drug

31 Mar 2011
Health advocates file petition with U.N. over proposed trade agreement among several countries

Health advocates file petition with U.N. over proposed trade agreement among several countries

31 Mar 2011
Molecular Templates ETB preclinical data against cancer to be presented at AACR meeting

Molecular Templates ETB preclinical data against cancer to be presented at AACR meeting

31 Mar 2011
Glasgow Professor discusses about new approach for CML treatment at UK conference

Glasgow Professor discusses about new approach for CML treatment at UK conference

31 Mar 2011
CEL-SCI to initiate Multikine Phase III trial against head and neck cancer in Israel

CEL-SCI to initiate Multikine Phase III trial against head and neck cancer in Israel

31 Mar 2011

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback